Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Moore

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
Blood|June 21, 2012
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Harry J Iland, Ken Bradstock, Shane G Supple, et al.
The Lancet. Haematology|December 22, 2015
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialHarry J Iland, Marnie Collins, Ken Bradstock, et al.
The New England Journal of Medicine|June 13, 2025
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and CyclosporinDavid J Curtis, Sushrut S Patil, John Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock Do Not Predict Treatment Effect of Hydrocortisone on Mortality. A Nested Cohort StudyJeremy Cohen, Rinaldo Bellomo, Laurent Billot, et al.
Nature Communications|February 13, 2020
Sub-picosecond charge-transfer at near-zero driving force in polymer:non-fullerene acceptor blends and bilayersYufei Zhong, Martina Causa', Gareth John Moore, et al.
Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.
Blood|January 29, 2021
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxisGlen A Kennedy, Siok-Keen Tey, Luke Buizen, et al.
Cell Reports|October 23, 2021
Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosisCatherine R Armbruster, Christopher W Marshall, Arkadiy I Garber, et al.
The British Journal of Surgery|October 24, 2024
Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/perioperative quality initiative (POQI) consensus statement on prehabilitation in oesophagogastric surgeryRobert C Walker, Sowrav Barman, Philip H Pucher, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Blood|June 21, 2012
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Harry J Iland, Ken Bradstock, Shane G Supple, et al.
The Lancet. Haematology|December 22, 2015
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialHarry J Iland, Marnie Collins, Ken Bradstock, et al.
The New England Journal of Medicine|June 13, 2025
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and CyclosporinDavid J Curtis, Sushrut S Patil, John Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock Do Not Predict Treatment Effect of Hydrocortisone on Mortality. A Nested Cohort StudyJeremy Cohen, Rinaldo Bellomo, Laurent Billot, et al.
Nature Communications|February 13, 2020
Sub-picosecond charge-transfer at near-zero driving force in polymer:non-fullerene acceptor blends and bilayersYufei Zhong, Martina Causa', Gareth John Moore, et al.
Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.
Blood|January 29, 2021
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxisGlen A Kennedy, Siok-Keen Tey, Luke Buizen, et al.
Cell Reports|October 23, 2021
Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosisCatherine R Armbruster, Christopher W Marshall, Arkadiy I Garber, et al.
The British Journal of Surgery|October 24, 2024
Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/perioperative quality initiative (POQI) consensus statement on prehabilitation in oesophagogastric surgeryRobert C Walker, Sowrav Barman, Philip H Pucher, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Pageof 28